Account (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid
- Catalog No. :
- ACPEBO994
- CAS No. :
- 47896-63-9
- Molecular Formula :
- C36H55N11O10
- Molecular Weight :
- 801.90
IUPAC Name:(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid |
|---|---|
| IUPAC Name | (2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid |
| MDL No. | MFCD00214589 |
| Molecular Formula | C36H55N11O10 |
| Molecular Weight | 801.90 |
| SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O |
| InChI Key | SYDDLSICWJNDAM-GKUXVWPZSA-N |
| Synonym | Angiotensin I/II (1-6) H-Asp-Arg-Val-Tyr-Ile-His-OH;ANGIOTENSIN I/II (1-6);ANGIOTENSIN 1/2 (1-6);H2N-DRVYIH-OH;H-ASP-ARG-VAL-TYR-ILE-HIS-OH;ASP-ARG-VAL-TYR-ILE-HIS;1-6-Angiotensin II, 5-L-isoleucine-;Angiotensin I/II (16),Angiotensin I/II (1-6),Inhibitor,inhibit,Angiotensin I/II (1 6),Angiotensin Receptor |
| CAS No. | 47896-63-9 |
Synthetic Route by SureRoute
2. ACPEBO994 Molecular Building Block Synthetic Route
(2R,5S,8S,11S,14S,17S,20S)-5-((1H-Imidazol-4-yl)methyl)-20-amino-8-((S)-sec-butyl)-17-(3-guanidinopropyl)-11-(4-hydroxybenzyl)-14-isopropyl-2-methyl-4,7,10,13,16,19-hexaoxo-3,6,9,12,15,18-hexaazadocosanedioic acid
(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-5-((R)-sec-butyl)-1-((R)-2-(((S)-1-(((S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrrolidin-1-yl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid
(2S,5S,8S,11S,14S,17S)-2-((1H-Imidazol-5-yl)methyl)-17-amino-5-((S)-sec-butyl)-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-guanidinopropyl)-8-(4-hydroxybenzyl)-11-isopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid xacetic acid